J. Shában

The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

P. Valensi, Marian Benroubi, Janusz Gumprecht et al. · International Journal of Clinical Practice · 2008 · 87 citations

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix^®30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

P. Valensi, Marian Benroubi, Jakub Gumprecht et al. · International Journal of Clinical Practice · 2009 · 80 citations · Full text

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix^®30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE^™observational study

Janusz Gumprecht, Marian Benroubi, Ryuzo Kawamori et al. · International Journal of Clinical Practice · 2009 · 46 citations · Full text

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix^®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

Shreyas Shah, Marian Benroubi, Jakub Gumprecht et al. · International Journal of Clinical Practice · 2009 · 44 citations · Full text

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study

Itamar Raz, Stephen Stranks, R. Filipczak et al. · Clinical Therapeutics · 2005 · 30 citations

Biphasic Insulin, Diabetes Management, Insulin Management +8